iNOS Activity Is Required for the Therapeutic Effect of Mesenchymal Stem Cells in Experimental Systemic Sclerosis
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.03056
Full Text
Open PDFAbstract
Available in full text
Date
December 21, 2018
Authors
Publisher
Frontiers Media SA